Palantir Faces Scrutiny Over Alleged Contract Breach With NHS: Report – Palantir Technologies (NYSE:PLTR)

The UK’s National Health Service (NHS) is investigating Palantir Technologies’ potential breach of contract over an unauthorised influencer marketing campaign. The campaign aimed to address data privacy concerns amid criticism of Palantir’s data platform project, which is part of a £330m ($419m) venture. The NHS contract specifies that Palantir must not make public references to the contract without prior consent. Campaign organisers were criticised, with accusations of spreading misinformation about Palantir’s work.